Tag Archives: target list

LSN Summer Reading Series Chapter 9: “Global Target List—Match Your Firm with Investors That Are a Fit”

23 Jul

By Lucy Parkinson, Senior Research Manager, LSN

lucy 10*10

Last week, we provided an overview of the infrastructure required to execute an outbound campaign.  This week, we take a deeper look at how to build your target list of investors.

Chapter 9: “Global Target List—Match Your Firm with Investors That Are a Fit” explains the importance of finding alignment between your life science company and an investor’s interests.  Here we outline how to use information on past financing rounds to uncover potential investors, and how to screen these leads to find active investors that may be interested in your company’s technology.  Finally, we’ll anatomize an investment mandate, and examine the factors that determine fit, including your location, the type of product you’re developing, and the stage of development your asset has reached.

Click here to download/print the PDF.

Next week, join us for Chapter 10: “Phone Canvassing.”

Enjoyed the preview? Buy now from Amazon.com or Barnes & Noble

Bookcover-Front

Your Target List: Who Is Not Investing

3 Jul

By Michael Quigley, Director of Research, LSN

mike-2

As a fundraising entrepreneur, knowing who is actively investing and who is not has the potential to increase the efficiency of your campaign by 30%, if not more.

Who is “not currently allocating” is one of the most valuable data points that we gather on the life science investment community. In this category we put any investor who has made investments in the space over the past five years and is in the process of fundraising, winding down a fund, or moving out of the space completely. Of the investors we have spoken to over the past year, we have found that approximately 30% are not currently looking to make new investments.

Why is this important? Because investors who aren’t allocating tend to be the slowest to respond to emails and voicemails, which can mean weeks—if not months—of wasted effort, as you try again and again to reach investors that are not seeking opportunities.

When we analyzed our data further, things got even more interesting. Of the investors we have spoken with who are not currently allocating, two-thirds are VCs; of the investors who are allocating, only one-third are VCs. This demonstrates a point we have discussed in this newsletter before: a large number of previously active life science VC investors are now raising their own funds, winding down, or phasing out of the life science sector.

The bottom line is that by knowing who is not actively allocating, you can identify all the players in your space who are seeking opportunities and substantially increase the efficiency and likelihood of successfully raising capital.  Too often fundraising executives use a shotgun approach, reaching out and trying to touch everyone who may or may not be investing in their space. This tactic creates a lot of needless noise and wasted time for both parties. A little extra knowledge regarding the current state of the targeted investor can go a long way toward making a fundraising executive much more productive in seeking capital.

%d bloggers like this: